SIGA TECHNOLOGIES INC (SIGA)

US8269171067 - Common Stock

10.15  +0.71 (+7.52%)

After market: 10.24 +0.09 (+0.89%)

Fundamental Rating

8

Taking everything into account, SIGA scores 8 out of 10 in our fundamental rating. SIGA was compared to 198 industry peers in the Pharmaceuticals industry. Both the health and profitability get an excellent rating, making SIGA a very profitable company, without any liquidiy or solvency issues. SIGA may be a bit undervalued, certainly considering the very reasonable score on growth This makes SIGA very considerable for value and quality investing!



8

1. Profitability

1.1 Basic Checks

In the past year SIGA was profitable.
SIGA had a positive operating cash flow in the past year.
SIGA had positive earnings in 4 of the past 5 years.
Of the past 5 years SIGA 4 years had a positive operating cash flow.

1.2 Ratios

SIGA has a better Return On Assets (26.76%) than 98.97% of its industry peers.
SIGA has a better Return On Equity (34.57%) than 95.38% of its industry peers.
SIGA's Return On Invested Capital of 32.27% is amongst the best of the industry. SIGA outperforms 98.46% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SIGA is significantly above the industry average of 16.38%.
The last Return On Invested Capital (32.27%) for SIGA is above the 3 year average (29.61%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 26.76%
ROE 34.57%
ROIC 32.27%
ROA(3y)25.51%
ROA(5y)22.1%
ROE(3y)31.46%
ROE(5y)26.08%
ROIC(3y)29.61%
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 48.65%, SIGA belongs to the top of the industry, outperforming 98.46% of the companies in the same industry.
SIGA's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 59.82%, SIGA belongs to the best of the industry, outperforming 98.97% of the companies in the same industry.
SIGA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 87.27%, SIGA belongs to the top of the industry, outperforming 90.26% of the companies in the same industry.
In the last couple of years the Gross Margin of SIGA has grown nicely.
Industry RankSector Rank
OM 59.82%
PM (TTM) 48.65%
GM 87.27%
OM growth 3Y-3.79%
OM growth 5Y-4.16%
PM growth 3Y2.6%
PM growth 5Y-11.26%
GM growth 3Y-0.18%
GM growth 5Y1.85%

9

2. Health

2.1 Basic Checks

SIGA has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SIGA has less shares outstanding than it did 1 year ago.
SIGA has less shares outstanding than it did 5 years ago.
SIGA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 9.30 indicates that SIGA is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.30, SIGA belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
SIGA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.3
ROIC/WACC3.5
WACC9.22%

2.3 Liquidity

SIGA has a Current Ratio of 4.42. This indicates that SIGA is financially healthy and has no problem in meeting its short term obligations.
SIGA's Current ratio of 4.42 is fine compared to the rest of the industry. SIGA outperforms 61.54% of its industry peers.
SIGA has a Quick Ratio of 3.23. This indicates that SIGA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SIGA (3.23) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.42
Quick Ratio 3.23

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.70% over the past year.
Measured over the past years, SIGA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.55% on average per year.
SIGA shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.25%.
The Revenue for SIGA have been decreasing by -21.76% on average. This is quite bad
EPS 1Y (TTM)99.7%
EPS 3Y10.18%
EPS 5Y-28.55%
EPS growth Q2Q10200%
Revenue 1Y (TTM)26.25%
Revenue growth 3Y3.83%
Revenue growth 5Y-21.76%
Revenue growth Q2Q921.76%

3.2 Future

The Earnings Per Share is expected to grow by 8.68% on average over the next years. This is quite good.
SIGA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.64% yearly.
EPS Next Y26.69%
EPS Next 2Y8.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year72.07%
Revenue Next 2Y23.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.68, the valuation of SIGA can be described as very reasonable.
Based on the Price/Earnings ratio, SIGA is valued cheaper than 92.82% of the companies in the same industry.
When comparing the Price/Earnings ratio of SIGA to the average of the S&P500 Index (28.28), we can say SIGA is valued rather cheaply.
A Price/Forward Earnings ratio of 8.43 indicates a reasonable valuation of SIGA.
94.87% of the companies in the same industry are more expensive than SIGA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.88, SIGA is valued rather cheaply.
Industry RankSector Rank
PE 10.68
Fwd PE 8.43

4.2 Price Multiples

95.90% of the companies in the same industry are more expensive than SIGA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SIGA is valued cheaper than 93.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.61
EV/EBITDA 6.19

4.3 Compensation for Growth

SIGA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SIGA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y8.68%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.34%, SIGA is a good candidate for dividend investing.
SIGA's Dividend Yield is rather good when compared to the industry average which is at 4.21. SIGA pays more dividend than 99.49% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SIGA pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.34%

5.2 History

SIGA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

SIGA pays out 47.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP47.22%
EPS Next 2Y8.68%
EPS Next 3YN/A

SIGA TECHNOLOGIES INC

NASDAQ:SIGA (5/3/2024, 7:18:21 PM)

After market: 10.24 +0.09 (+0.89%)

10.15

+0.71 (+7.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap721.87M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 10.34%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 10.68
Fwd PE 8.43
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 26.76%
ROE 34.57%
ROCE
ROIC
ROICexc
ROICexgc
OM 59.82%
PM (TTM) 48.65%
GM 87.27%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.42
Quick Ratio 3.23
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)99.7%
EPS 3Y10.18%
EPS 5Y
EPS growth Q2Q
EPS Next Y26.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.25%
Revenue growth 3Y3.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y